Cargando…

Association between cadmium and anti-Mullerian hormone in premenopausal women at particular ages

BACKGROUND: Anti-Mullerian hormone (AMH) in women is secreted by granulosa cells of antral follicles. AMH appears to be a very stable marker for ovarian function. It may be used to diagnosis cases of premature ovarian failure, polycystic ovary syndrome (PCOS), and ovarian tumors. It has been suggest...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Yu min, Chung, Hye Won, Jeong, Kyungah, Sung, Yeon-Ah, Lee, Hyejin, Ye, Shinhee, Ha, Eun-Hee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6038324/ https://www.ncbi.nlm.nih.gov/pubmed/30002855 http://dx.doi.org/10.1186/s40557-018-0255-7

Ejemplares similares

Blood cadmium and volume of uterine fibroids in premenopausal women
por: Ye, Shinhee, et al.
Publicado: (2017)

The Association of Ovarian Reserve with Exposure to Bisphenol A and Phthalate in Reproductive-aged Women
por: Park, So Yun, et al.
Publicado: (2020)

Serum Anti-Müllerian Hormone Levels before Surgery in Patients with Ovarian Endometriomas Compared to Other Benign Ovarian Cysts
por: Jeon, Ji Hyun, et al.
Publicado: (2015)

Differentiation between polycystic ovary syndrome and polycystic ovarian morphology by means of an anti-Müllerian hormone cutoff value
por: Song, Do Kyeong, et al.
Publicado: (2017)

Serum Anti-Mullerian Hormone Levels Might Indicate Premenopausal Endometrial Lesions
por: Yao, Yingsha, et al.
Publicado: (2023)

Cadmium, Lead, and Mercury in Relation to Reproductive Hormones and Anovulation in Premenopausal Women
por: Pollack, Anna Z., et al.
Publicado: (2011)

Reference intervals of anti‐Müllerian hormone in Korean women
por: Choi, Rihwa, et al.
Publicado: (2022)

The expression of Müllerian inhibiting substance/anti-Müllerian hormone type II receptor in myoma and adenomyosis
por: Kim, Shin Young, et al.
Publicado: (2018)

Low anti-Müllerian hormone levels are associated with an increased risk of incident early-onset vasomotor symptoms among premenopausal women
por: NamGoung, SunJu, et al.
Publicado: (2022)

Relationship between the characteristic traits of polycystic ovary syndrome and susceptibility genes
por: Hong, So-hyeon, et al.
Publicado: (2020)

Diagnostic and predictive accuracy of anti-mullerian hormone for ovarian function after chemotherapy in premenopausal women with early breast cancer
por: Anderson, Richard A., et al.
Publicado: (2022)

Correlation between the Serum Luteinizing Hormone to Folliclestimulating Hormone Ratio and the Anti-Müllerian Hormone Levels in Normo-ovulatory Women
por: Lee, Jong Eun, et al.
Publicado: (2015)

Post-chemotherapy serum anti-Müllerian hormone level predicts ovarian function recovery
por: Kim, Hyun-Ah, et al.
Publicado: (2018)

Surgical impact on serum anti-Müllerian hormone in women with benign ovarian cyst: A prospective study
por: Jang, Won Kyu, et al.
Publicado: (2014)

Does the Serum Vitamin D Status and its Possible Effect on Serum Anti-Müllerian Hormone Levels Predict Fertility in Premenopausal Women?
por: Lawal, Oyinkansola Islamiyat
Publicado: (2021)

Serum Müllerian inhibiting substance levels are lower in premenopausal women with breast precancer and cancer
por: McCoy, Andrew C, et al.
Publicado: (2011)

Concurrent Gonadotropin-Releasing Hormone Agonist Administration with Chemotherapy Improves Neoadjuvant Chemotherapy Responses in Young Premenopausal Breast Cancer Patients
por: Kim, Hee Jeong, et al.
Publicado: (2015)

Clinical application of anti-Müllerian hormone as a predictor of controlled ovarian hyperstimulation outcome
por: Lee, Jae Eun, et al.
Publicado: (2012)

Clinical application of serum anti-Müllerian hormone in women
por: Oh, So Ra, et al.
Publicado: (2019)

Non-alcoholic fatty liver disease is associated with hyperandrogenism in women with polycystic ovary syndrome
por: Hong, So-hyeon, et al.
Publicado: (2023)

Anti-Müllerian Hormone Signal Transduction involved in Müllerian Duct Regression
por: Cate, Richard L.
Publicado: (2022)

Insulin Resistance Increases Serum Immunoglobulin E Sensitization in Premenopausal Women
por: Lee, Seung Eun, et al.
Publicado: (2021)

Survival Outcomes in Premenopausal Patients With Invasive Lobular Carcinoma
por: Yoon, Tae In, et al.
Publicado: (2023)

Bilateral Salpingo-oophorectomy Compared to Gonadotropin-Releasing Hormone Agonists in Premenopausal Hormone Receptor?Positive Metastatic Breast Cancer Patients Treated with Aromatase Inhibitors
por: Suh, Koung Jin, et al.
Publicado: (2017)

Towards international standardization of immunoassays for Müllerian inhibiting substance/anti-Müllerian hormone
por: Ferguson, Jackie MC, et al.
Publicado: (2018)

Clinical Utilities of Anti-Müllerian Hormone
por: Russell, Nicole, et al.
Publicado: (2022)

Ovarian Function Suppression With Luteinizing Hormone-Releasing Hormone Agonists for the Treatment of Hormone Receptor-Positive Early Breast Cancer in Premenopausal Women
por: Lu, Yen-Shen, et al.
Publicado: (2021)

Clinical and Biochemical Profiles according to Homeostasis Model Assessment-insulin Resistance (HOMA-IR) in Korean Women with Polycystic Ovary Syndrome
por: Lee, Da Eun, et al.
Publicado: (2014)

Association of Long-term Use of Low-Dose Aspirin as Chemoprevention With Risk of Lung Cancer
por: Ye, Shinhee, et al.
Publicado: (2019)

Relation between dietary cadmium intake and biomarkers of cadmium exposure in premenopausal women accounting for body iron stores
por: Julin, Bettina, et al.
Publicado: (2011)

Anti-Mullerian Hormone Changes Following Laparoscopic Ovarian Cystectomy: A Prospective Comparative Study
por: Cho, Hye-yon, et al.
Publicado: (2021)

Ovarian dysgerminoma with Müllerian anomaly: a case report
por: Kim, Ha Na, et al.
Publicado: (2020)

Functional profiles of Müllerian inhibiting substance/anti-Müllerian hormone (MIS/AMH) in primarily cultured endometrial cancer cells
por: Kim, Sang Il, et al.
Publicado: (2021)

Müllerian inhibiting substance/anti-Müllerian hormone: A novel treatment for gynecologic tumors
por: Kim, Jang Heub, et al.
Publicado: (2014)

Müllerian Duct Anomalies and Anti-Müllerian Hormone Levels in Women With Polycystic Ovary Syndrome
por: Yang, Min, et al.
Publicado: (2023)

What is the role of robotic surgery in ovarian cystectomy with fertility preservation?
por: Lee, Ju Hye, et al.
Publicado: (2023)

Controversies in hormonal adjuvant therapy for premenopausal patients
por: Howell, A
Publicado: (2009)

Survey of clinicians on the use of adjuvant therapy for premenopausal women with breast cancer
por: Lee, Young-Won, et al.
Publicado: (2023)

Association between Prenatal Exposure to Cadmium and Atopic Dermatitis in Infancy
por: Kim, Ja Hyeong, et al.
Publicado: (2013)

Decreased Anti-Müllerian hormone and Anti-Müllerian hormone receptor type 2 in hypothalami of old Japanese Black cows
por: KEREILWE, Onalenna, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7vph5nl22t3cj7btbp3elau32t